Key result
Higher WBC/HDL ratio is linked to ~26% higher odds of poor stroke outcomes per unit.
Why the study?
Inflammation and lipid metabolism play critical roles in acute ischemic stroke, prompting evaluation of the white blood cell to high-density lipoprotein cholesterol ratio as a prognostic biomarker for 90-day functional outcomes.
Does an elevated baseline WBC/HDL ratio predict unfavorable 90-day functional outcomes (mRS > 2) in patients with acute ischemic stroke?
Cohort (n=837)
No
Does an elevated baseline WBC/HDL ratio predict unfavorable 90-day functional outcomes (mRS > 2) in patients with acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
The admission WBC/HDL ratio shows a linear, independent positive association with 90-day functional disability in acute ischemic stroke, offering a simple, routine laboratory biomarker for early risk stratification.
BACKGROUND: Inflammation and lipid metabolism play critical roles in the pathogenesis and outcome of acute ischemic stroke (AIS). The white blood cell to high-density lipoprotein cholesterol ratio (WBC/HDL) has been identified as a novel composite biomarker reflecting systemic inflammatory status and anti-inflammatory capacity. We sought to evaluate the prognostic value of WBC/HDL in predicting 90-day functional outcomes among AIS patients. METHODS: We retrospectively enrolled 837 AIS patients. Baseline WBC/HDL ratios were calculated at admission. The primary endpoint was 90-day functional outcome, assessed by the modified Rankin Scale, with scores > 2 defined as unfavorable outcomes. Associations between WBC/HDL and outcomes were assessed through logistic regression, restricted cubic spline (RCS) curves, and subgroup analysis. RESULTS: Higher WBC/HDL ratios were significantly associated with poor functional outcomes. The association remained robust after adjustment for key covariates (adjusted OR: 1.2589; p = 0.0001). The highest WBC/HDL tertile had nearly twice the risk of poor outcomes compared with the lowest tertile. The RCS analysis demonstrated a linear dose-response relationship. Subgroup analyses revealed a consistent relationship across sex, stroke severity, and comorbidity groups, without significant interactions. CONCLUSIONS: The WBC/HDL ratio independently predicts 90-day functional outcomes in AIS and represents a practical biomarker for early risk stratification.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted a cohort in Acute ischemic stroke (AIS) (n=837). Baseline white blood cell to high-density lipoprotein cholesterol ratio (WBC/HDL) vs. Lower WBC/HDL ratio (continuous per unit increase, or lowest tertile T1) was evaluated on 90-day unfavorable functional outcome (modified Rankin Scale [mRS] > 2) (OR 1.2589, 95% CI 1.1200-1.4201, p=0.0001). Elevated baseline WBC/HDL ratio independently predicted unfavorable 90-day functional outcomes (mRS >2) in acute ischemic stroke patients.
Synapse has enriched 10 related papers. Consider them for comparative context: